Stock Events

Stock Events

PRF Technologies 

$1.6500
37
-$0.20-10.81% Thursday 20:00

Statistics

Day High
1.75
Day Low
1.39
52W High
11.85
52W Low
1.34
Volume
448,900
Avg. Volume
-
Mkt Cap
3.32M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

26MarExpected
Q4 2023
Q1 2024
Q2 2024
Q3 2024
Q4 2024
Q3 2025
Q4 2025
-26.4
-18.4
-10.4
-2.4
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-29.18MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PRFX. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pacira BioSciences
PCRX
Mkt Cap904.61M
Pacira Biosciences specializes in non-opioid pain management, directly competing with PainReform's post-operative pain solutions.
Heron Therapeutics
HRTX
Mkt Cap75.73M
Heron Therapeutics focuses on improving the patient experience by developing best-in-class treatments for acute and chronic pain, similar to PainReform's objectives.
Trevena
TRVN
Mkt Cap9,501
Trevena, Inc. develops novel medicines for patients affected by pain, offering alternatives that could compete with PainReform's products.
Evolus
EOLS
Mkt Cap444.52M
Evolus operates in the medical aesthetics market but its focus on non-surgical treatments could indirectly compete with PainReform's pain management solutions.
CorMedix
CRMD
Mkt Cap685.67M
CorMedix Inc. focuses on preventing and treating infections and inflammatory diseases, which could overlap with PainReform's target market in post-operative care.
Nektar Therapeutics
NKTR
Mkt Cap2.07B
Nektar Therapeutics works on drug development that includes pain management solutions, potentially competing with PainReform's portfolio.
Collegium Pharmaceutical
COLL
Mkt Cap1.12B
Collegium Pharmaceutical is dedicated to developing and commercializing new medications for pain management, directly competing with PainReform.

About

PRF Technologies Ltd. operates as a specialized pharmaceutical company, currently in the clinical development stage, with a focus on pioneering treatments that deliver sustained post-surgical pain management. Central to its pipeline is PRF-110, a distinctive clear, viscous, oil-based solution. This innovative product is engineered for direct application into surgical incisions, aiming to provide targeted and prolonged alleviation of discomfort following operations. PRF-110 is presently undergoing assessment in two pivotal Phase 3 clinical trials, specifically for individuals recovering from bunionectomy and hernia repair procedures. The company, which was originally incorporated in 2007 under the name PainReform Ltd., maintains its headquarters in Tel Aviv, Israel.
Show more...
CEO
Dr. Ehud Geller Ph.D.
Employees
2
Country
United States
ISIN
IL0011651580

Listings

BOATS
BOATS
PRFX.BOATS
XNAS
US
PRFX

0 Comments

Share your thoughts

FAQ

What is PRF Technologies stock price today?▼
The current price of PRFX is $1.65 USD — it has decreased by -10.81% in the past 24 hours. Watch PRF Technologies stock price performance more closely on the chart.
What is PRF Technologies stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange PRF Technologies stocks are traded under the ticker PRFX.
Is PRF Technologies stock price growing?▼
PRFX stock has risen by +21.32% compared to the previous week, the month change is a +2.48% rise, over the last year PRF Technologies has showed a -79.44% decrease.
What is PRF Technologies market cap?▼
Today PRF Technologies has the market capitalization of 3.32M
What is PRF Technologies revenue for the last year?▼
PRF Technologies revenue for the last year amounts to 0 USD.
What is PRF Technologies net income for the last year?▼
PRFX net income for the last year is -29.18M USD.
How many employees does PRF Technologies have?▼
As of June 20, 2026, the company has 2 employees.
In which sector is PRF Technologies located?▼
PRF Technologies operates in the Health & Wellness sector.
When did PRF Technologies complete a stock split?▼
The last stock split for PRF Technologies was on February 06, 2026 with a ratio of 1:5.
Where is PRF Technologies headquartered?▼
PRF Technologies is headquartered in Tel Aviv-Yafo, United States.